Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Finally! The 100% Chinese-produced Targeted Anti-cancer Drug Fruquintinib Developed by Hutchison MediPharma for 13 Years to be Marketed

CaicaiSeptember 07, 2018

Tag: Fruquintinib , Hutchison MediPharma , marketing , colorectal cancer

PharmaSources Customer Service